ArticleOpen medicine (Warsaw, Poland)2022

miR-212-5p inhibits nasopharyngeal carcinoma progression by targeting METTL3.

Hongyu Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.